Heparin-Induced Hyperkalemia Assessment Utilizing the Naranjo Adverse Drug Reaction Probability Scale: A 40-Year Systematic Review
- PMID: 40278538
- PMCID: PMC12030744
- DOI: 10.3390/pharmacy13020055
Heparin-Induced Hyperkalemia Assessment Utilizing the Naranjo Adverse Drug Reaction Probability Scale: A 40-Year Systematic Review
Abstract
Background: Adverse drug reactions have been reported as leading causes of morbidity and mortality. Unfractionated heparin- and low-molecular-weight heparin-induced hyperkalemia are side effects that have been reported in approximately 7 to 8% of heparin-treated patients. Algorithms, assessment tools, and decision aids are needed to assist in determining the causality of these adverse drug reactions.
Aim: The aim of this study was to determine the number of case reports of hyperkalemia resulting from unfractionated heparin or low-molecular-weight heparin use by utilizing the Naranjo Adverse Drug Reaction Probability Scale.
Methods: PubMed, International Pharmaceutical Abstracts, and the Cochrane Library were searched for relevant publications. Search terms and Boolean operators, including "hyperkalemia AND heparin", "hyperkalemia AND low molecular weight heparin", "heparin AND hypoaldosteronism", and "low molecular weight heparin AND hypoaldosteronism", were used. Searches were limited to case reports and human specimens.
Results: A total of 29 case reports were identified, incorporating 38 patient cases. Of the 38 patient cases, 5 [4 involving unfractionated heparin and 1 involving low-molecular-weight heparin] (13.2%) utilized the Naranjo Adverse Drug Reaction Probability Scale to identify the possibility of an adverse drug reaction occurring due to exposure to unfractionated or low-molecular-weight heparin as probable.
Conclusions: The available evidence suggests that clinicians' use of the Naranjo Adverse Drug Reaction Probability Scale to determine the potential of hyperkalemia occurring due to exposure to unfractionated heparin and low-molecular-weight heparin is limited. Clinicians should be encouraged to utilize an objective monitoring tool to help standardize assessment of causality for all adverse drug reactions.
Keywords: adverse drug reaction; heparin; hyperkalemia; hypoaldosteronism; low-molecular-weight heparin; unfractionated heparin.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
Similar articles
-
Heparin-induced hyperkalemia, can LMWH cause hyperkalemia? A systematic review.EJHaem. 2023 Oct 3;4(4):1110-1116. doi: 10.1002/jha2.801. eCollection 2023 Nov. EJHaem. 2023. PMID: 38024642 Free PMC article. Review.
-
Misuse of the Naranjo Adverse Drug Reaction Probability Scale in toxicology.Clin Toxicol (Phila). 2013 Jul;51(6):461-6. doi: 10.3109/15563650.2013.811588. Epub 2013 Jun 18. Clin Toxicol (Phila). 2013. PMID: 23777343 Free PMC article. Review.
-
Unfractionated heparin as a safe alternative in a case of low molecular weight heparin-induced thrombocytosis: A case report.Ann Med Surg (Lond). 2021 Apr 30;65:102370. doi: 10.1016/j.amsu.2021.102370. eCollection 2021 May. Ann Med Surg (Lond). 2021. PMID: 34026103 Free PMC article.
-
Heparin-induced hyperkalemia in a patient diagnosed with thyroid storm.Ann Pharmacother. 2013 Sep;47(9):1213-7. doi: 10.1177/1060028013503130. Ann Pharmacother. 2013. PMID: 24259739
-
Evaluation of naranjo adverse drug reactions probability scale in causality assessment of drug-induced liver injury.Aliment Pharmacol Ther. 2008 May;27(9):780-9. doi: 10.1111/j.1365-2036.2008.03655.x. Epub 2008 Feb 18. Aliment Pharmacol Ther. 2008. PMID: 18284654
References
-
- Linhardt R.J., Gunay N.S. Production and chemical processing of low molecular weight heparins. Semin. Thromb. Hemost. 1999;25((Suppl. S3)):5–16. - PubMed
Publication types
LinkOut - more resources
Full Text Sources